Outcomes After Hybrid Palliation for Infants With Critical Left Heart Obstruction

Madison B Argo1, David J Barron2, Pirooz Eghtesady3

  • 1Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA; Division of Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

Hybrid palliation offers initial management for critical left heart obstruction in infants. However, high mortality persists, with outcomes varying based on patient factors and interventions like ductal stenting.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Critical Care Medicine

Background:

  • Hybrid palliation, involving bilateral pulmonary artery banding and potentially ductal stenting, is a primary strategy for infants with critical left heart obstruction.
  • This approach serves as a temporary measure before definitive surgical interventions.

Purpose of the Study:

  • To identify patient characteristics influencing outcomes in infants undergoing hybrid palliation.
  • To analyze factors associated with subsequent major clinical endpoints, including biventricular repair, Fontan procedure, transplantation, or death.

Main Methods:

  • Analysis of prospectively enrolled infants (n=214) with critical left heart obstruction from 2005-2019.
  • Utilized multivariable hazard modeling with competing risk methodology to assess outcomes.
  • Data collected from 24 institutions within the Congenital Heart Surgeons' Society cohort.

Main Results:

  • 70% of infants had preoperative comorbidities. Overall 12-year survival was 55%.
  • At 5 years post-hybrid palliation: 9% underwent biventricular repair, 36% had a Fontan procedure, 12% received transplantation, and 35% died.
  • Factors like ductal stent absence, older age, and specific cardiac anatomy influenced transplantation risk. Low birth weight, genetic syndromes, and tricuspid regurgitation were linked to increased mortality.

Conclusions:

  • Hybrid palliation for critical left heart obstruction in infants is associated with high mortality.
  • This strategy can facilitate biventricular repair in select cases or stabilize patients for univentricular palliation or transplantation.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12